Stay updated on Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from **v3.5.2** to **v3.5.3**, indicating a minor site release without changing the displayed study record information.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:57.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:29:47.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added new study details for Nadunolimab in combination with gemcitabine and carboplatin (TRIFOUR), including Phase Ib/II design and updated dates. Removed the prior TRIFOUR entry and related outdated notes.
    Difference
    0.4%
    Check dated 2026-04-09T21:31:40.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 added in the header; the previous version v3.4.3 was removed from the display.
    Difference
    0.0%
    Check dated 2026-03-19T05:08:18.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.2 to v3.4.3. No trial details or study data appear to be changed.
    Difference
    0.0%
    Check dated 2026-03-11T23:57:24.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices, including the government funding lapse notice and Revision: v3.4.1, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:03.000Z thumbnail image

Stay in the know with updates to Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.